The IMAGIO consortium brings together top-of-the-class partners with different technology and clinical expertise, working on multiple disease areas, from on-site diagnostics to curative and palliative treatment, facilitating cross fertilization and the emergence of IO-enabled combination therapies. The consortium includes 30 partners from 8 Member States and 2 Associated Country.
UNIVERSITAIR MEDISCH CENTRUM UTRECHT
ACADEMISCH ZIEKENHUIS LEIDEN
TECHNISCHE UNIVERSITEIT DELFT
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
Flash Pathology
STICHTING VU
Stichting Longkanker Nederland
ACADEMISCH ZIEKENHUIS MAASTRICHT
UNIVERSITEIT TWENTE
Nederlandse Leverpatienten Vereniging
JANSSEN PHARMACEUTICA NV
CANCER PATIENTS EUROPE
SIOP EUROPE
Nanovi A/S
SAINT-GOBAIN CRISTAUX & DETECTEURS
KLINIKUM DER UNIVERSITAET ZU KOELN
PHILIPS GMBH
Gremse-IT GmbH
Thermosome GmbH
EBERHARD KARLS UNIVERSITAET TUEBINGEN
Profound Medical GmbH
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATIOUK Associated
IMAGINAB, INC
Pfizer Inc